Book contents
- Cambridge Handbook of Pain Medicine
- Cambridge Handbook of Pain Medicine
- Copyright page
- Contents
- Contributors
- Pain Handbook Introduction
- Part I Introduction to Pain: Pain Signaling Pathways
- Part II Common Categories of Pharmacologic Medications to Treat Chronic Pain
- Part III Chronic Pain Conditions Head and Neck
- Part IV Spine
- Part V Extremities
- Part VI Misc
- Part VII Adjunctive Therapy
- Chapter 39 Neuromodulation
- Chapter 40 Regenerative Medicine
- Chapter 41 Cognitive Therapy
- Chapter 42 Alternative Therapy
- Chapter 43 Role of CBD in Chronic Pain
- Index
- References
Chapter 43 - Role of CBD in Chronic Pain
from Part VII - Adjunctive Therapy
Published online by Cambridge University Press: 01 December 2023
Book contents
- Cambridge Handbook of Pain Medicine
- Cambridge Handbook of Pain Medicine
- Copyright page
- Contents
- Contributors
- Pain Handbook Introduction
- Part I Introduction to Pain: Pain Signaling Pathways
- Part II Common Categories of Pharmacologic Medications to Treat Chronic Pain
- Part III Chronic Pain Conditions Head and Neck
- Part IV Spine
- Part V Extremities
- Part VI Misc
- Part VII Adjunctive Therapy
- Chapter 39 Neuromodulation
- Chapter 40 Regenerative Medicine
- Chapter 41 Cognitive Therapy
- Chapter 42 Alternative Therapy
- Chapter 43 Role of CBD in Chronic Pain
- Index
- References
Summary
Introduction to Cannabidiol (CBD)
- Type
- Chapter
- Information
- Cambridge Handbook of Pain Medicine , pp. 349 - 353Publisher: Cambridge University PressPrint publication year: 2023
References
Häuser, W, Welsch, P, Klose, P, Radbruch, L, Fitzcharles, MA. Efficacy, tolerability and safety of cannabis-based medicines for cancer pain: A systematic review with meta-analysis of randomised controlled trials. Schmerz. 2019;33(5):424–436 Published online 2019. https://doi.org/10.1007/s00482-019-0373-3.CrossRefGoogle ScholarPubMed
Louis-Gray, K, Tupal, S, Premkumar, LS. TRPV1: A common denominator mediating antinociceptive and antiemetic effects of cannabinoids. Int J Mol Sci. 2022;23(17):10016. Published online 2022. https://doi.org/10.3390/ijms231710016.CrossRefGoogle ScholarPubMed
Köstenberger, M, Nahler, G, Jones, TM, Neuwersch, S, Likar, R. The role of cannabis, cannabidiol and other cannabinoids in chronic pain: The perspective of physicians. J Neuroimmune Pharmacol. 2022;17(1–2):38–333. https://doi.org/10.1007/s11481-021-10010-x.CrossRefGoogle ScholarPubMed
MacCallum, CA, Russo, EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018;49:12–19. https://doi.org/10.1016/j.ejim.2018.01.004.CrossRefGoogle ScholarPubMed
Boehnke, KF, Yakas, L, Scott, JR et al. A mixed methods analysis of cannabis use routines for chronic pain management. J Cannabis Res. 2022;4(1):1–11. https://doi.org/10.1186/S42238-021-00116-7.CrossRefGoogle ScholarPubMed
Frane, N, Stapleton, E, Iturriaga, C et al. Cannabidiol as a treatment for arthritis and joint pain: An exploratory cross-sectional study. J Cannabis Res. 2022;4(1):47. https://doi.org/10.1186/s42238-022-00154-9.CrossRefGoogle Scholar
Henderson, LA, Kotsirilos, V, Cairns, EA et al. Medicinal cannabis in the treatment of chronic pain. Aust J Gen Pract. 2021;50. www.abs.gov.au/statistics/people/population/national-state-and-territory-population/dec-2020.CrossRefGoogle Scholar
Stephens, KL, Heineman, JT, Forster, GL, Timko, MP, Degeorge, BR. Cannabinoids and pain for the plastic surgeon: What is the evidence? Ann Plast Surg. 2022;88(5 Suppl 5):S508–S511. https://doi.org/10.1097/SAP.0000000000003128.CrossRefGoogle Scholar
Yu, CHJ, Rupasinghe, HPV. Cannabidiol-based natural health products for companion animals: Recent advances in the management of anxiety, pain, and inflammation. Res Vet Sci. 2021;140:38–46. https://doi.org/10.1016/J.RVSC.2021.08.001.CrossRefGoogle ScholarPubMed
Baraldi, C, lo Castro, F, Negro, A et al. Oral cannabinoid preparations for the treatment of chronic migraine: A retrospective study. Pain Med. 2022;23(2):396–402. https://doi.org/10.1093/PM/PNAB245.CrossRefGoogle ScholarPubMed
Jesus, CHA, Ferreira, MV, Gasparin, AT et al. Cannabidiol enhances the antinociceptive effects of morphine and attenuates opioid-induced tolerance in the chronic constriction injury model. Behav Brain Res. 2022;435:114076. https://doi.org/10.1016/J.BBR.2022.114076.CrossRefGoogle ScholarPubMed
Razavi, Y, Rashvand, M, Sharifi, A et al. Cannabidiol microinjection into the nucleus accumbens attenuated nociceptive behaviors in an animal model of tonic pain. Neurosci Lett. 2021;762:136141. https://doi.org/10.1016/J.NEULET.2021.136141.CrossRefGoogle Scholar
Chou, R, Wagner, J, Ahmed, AY et al. Living systematic review on cannabis and other plant-based treatments for chronic pain. Rockville (MD): Agency for Healthcare Research and Quality (US). Published online October 27, 2021. www.ncbi.nlm.nih.gov/books/NBK586045/. https://doi.org/10.23970/AHRQEPCCER250.CrossRefGoogle Scholar
Campos, RMP, Aguiar, AFL, Paes-Colli, Y et al. Cannabinoid therapeutics in chronic neuropathic pain: From animal research to human treatment. 2021;12:785176. Published online 2021. https://doi.org/10.3389/fphys.2021.785176.CrossRefGoogle Scholar